Clinical Development Part #2

Phase 4: Cameroon in field study COVID-19 plus qualitative research.

The first COVID 19 pilot will be conducted with the local NGO, Blessing Associates for Woman and Children (BAWC).

Over 100 patients will be involved in two health districts in the Limbe region lead by the CEO and founder, charismatic and well respected, Baiye Frida Ebai.

The objective of the first COVID pilot is to assess the impact of reward systems on patients getting vaccinated and patients returning for a second vaccination. We will conduct a thorough qualitative evaluation with both patients and healthcare workers

A field test will be conducted with the following objectives:

  1. Assess the feasibility and community acceptance of the Immunify.life disease management platform.
  2. Identify implementation issues.
  3. Assess the training and technology requirements.
  4. Collect success stores to support the launch.
  5. Support local community healthcare outcomes.

Phase 4: Kenya in field Study.

Following the qualitative evaluation Immunify.life will partner with MMUST University in Kenya to conduct a quantitative analysis of the impact of token rewards on patient and doctor behaviour.

Kenya is part of the Commonwealth of Nations and we will be collaborating with The Commonwealth Secretariat to fine tune the design to allow it to integrate with their COVID tracking dashboard that is used in 54 Commonwealth countries with a population of 2.6 billion.

We have instigated planning discussions with a prestigious research focused university MMUST, based in Kenya.

MMUST (Masinde Muliro University of Science and Technology) is the premier Science Technology and Innovation University in Kenya. It has approximately 17,000 students across its branches. Main Campus (Kakamega Town) www.mmust.ac.ke

The university has a focus on international collaboration and has previously executed agreements with Save the Children Fund a world leading NGO with 25,000 dedicated staff across 117 countries and as such is an excellent research partner.

Phase 6: Clinical study for publication.

The results of the Kenyan study will be used to inform the design of a larger scale multi-centre scientific study that will be robust to scientifically assess the impact of token rewards on behaviour.

We will collaborate with a major research organisation with an international profile to conduct the study and publish in a leading scientific journal. A recent article in Science Magazine has suggested that blockchain technology can play a role in managing pandemics.

Phase 7: In Planning for Q1 2022. Full Country COVID-19 driven multiple-disease pilot.

Further to the implementation of Phases 5 and 6 a small nation state is being identified in order to conduct a country-wide and full population roll-out of the full scope of the Immunify.Life ecosystem.

The roll out will be conducted in accordance with COVID-19 vaccination priorities and encompass a full clinical registry with general health and multi-disease coverage adapted to the in-country requirements.

Scope and Aim:

  • Full population coverage prioritised by COVID-19 vaccination monitoring and roll-out.
  • Full patient health record implementation and detailed multi-disease data capture.
  • Full patient record accessibility.
  • Full health facility data accessibility.
  • Full data consolidation for data with patient consent.
  • Patient and Healthcare worker incentivisation to ensure accelerated adoption, scaling and diligence in implementation.

The need to conduct this type of research was recently highlighted by one of the world’s most prestigious academic journals, Science Magazine.

“Timely and widespread dissemination of resources and information related to pathogenic threats plays a critical role in outbreak recognition, research, containment, and mitigation as stakeholders from government, public health industry, and academia seek to implement interventions and develop vaccines, diagnostics, and drugs. But there are persistent barriers to sharing and cooperative research and development in the context of epidemics, rooted in a lack of trust in confidentiality and reciprocity, ambiguity over resource ownership and conflicting public, private, and academic incentives. Here, we suggest how recent advances in blockchain and related technologies can enable decentralised mechanisms to help break down these systemic and largely non technological barriers”

https://science.sciencemag.org/content/368/6492/719/

Twitter | Website | Medium | Telegram

Immunify.life is a transformative and self-sustaining healthcare ecosystem on the Cardano blockchain powered by AI with self sovereign identification.